Joseph P Hagan
CIK 1465278 · Chief Executive Officer · last filed 2025-06-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$193.5K
Companies
4
Total Filings
72
Lifetime Open-Market Net
-$1.95M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Regulus Therapeutics Inc. (RGLS) Delisted | Chief Executive Officer | 225,674 | $8.16 | $1.84M | $94.1K | 43 | 2025-06-27 |
| AUPH | Director | 12,233 | $15.82 | $193.5K | -$906.5K | 4 | 2023-05-23 |
| Zosano Pharma Corp (ZSAN) Delisted | Director | 22,500 | $0.56 | $12.5K | $0 | 8 | 2021-06-14 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | Chief Business Officer | 13,026 | — | — | -$1.14M | 17 | 2015-02-05 |
Recent Filings · Page 2 of 8
72 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-20 | AUPH | Grant (A) | — | $0 | EDGAR |
| 2022-05-11 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-26 | Regulus Therapeutics Inc. (RGLS) Delisted | Mixed | +100,000 | $21.5K | EDGAR |
| 2022-01-04 | AUPH | Mixed | — | -$700.5K | EDGAR |
| 2021-06-16 | AUPH | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | Zosano Pharma Corp (ZSAN) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2021-05-17 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −4,186 | -$3.7K | EDGAR |
| 2021-04-16 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −4,144 | -$7.1K | EDGAR |
| 2021-04-16 | Regulus Therapeutics Inc. (RGLS) Delisted | Conv (C) | +75,850 | $0 | EDGAR |
| 2021-02-17 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −4,144 | -$7.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.